体质量指数对不孕症患者宫腔内人工授精结局的影响

Effect of body mass index on the outcome of intrauterine insemination in patients with infertility

  • 摘要:
    目的 探讨体质量指数(BMI)对不孕症患者宫腔内人工授精(IUI)结局的影响。
    方法 选取行第一周期IUI的不孕症患者1 393例为研究对象。根据BMI将患者分为BMI正常组(n=824)、超重组(n=394)和肥胖组(n=175)。比较3组的年龄、不孕年限、不孕类型、性激素、空腹血糖、空腹胰岛素、甲状腺功能、授精时机、前向运动精子数、生化妊娠率、临床妊娠率和流产率。多重线性回归分析BMI的影响因素; 二元Logistic回归分析年龄、BMI、空腹血糖、空腹胰岛素对IUI结局的影响。绘制受试者工作特征(ROC)曲线分析BMI对生化妊娠、临床妊娠的预测价值并计算Cut-off值。
    结果 3组的年龄、授精时间、前向运动精子数、临床妊娠率和流产率比较,差异无统计学意义(P>0.05)。肥胖组和超重组的不孕年限、空腹血糖和空腹胰岛素水平长于或高于BMI正常组,差异有统计学意义(P<0.05)。肥胖组促卵泡激素(FSH)水平低于BMI正常组和超重组,游离甲状腺素(FT4)水平高于超重和BMI正常组,差异有统计学意义(P<0.05)。肥胖组生化妊娠率高于BMI正常组,差异有统计学意义(P<0.05)。多重线性回归分析显示, BMI与FSH、雌二醇(E2)呈负相关(P<0.01), 与空腹血糖、空腹胰岛素呈正相关(P<0.01)。多因素二元Logistic回归分析显示,年龄、BMI为临床妊娠的影响因素(P<0.05); 年龄、BMI和空腹胰岛素为生化妊娠的影响因素(P<0.05)。ROC曲线显示, BMI预测生化妊娠和临床妊娠的曲线下面积(AUC)分别为0.608和0.610, Cut-off值均为23.05 kg/m2
    结论 BMI影响不孕患者的内分泌及糖脂代谢。BMI可作为独立因素预测IUI的生化妊娠、临床妊娠。

     

    Abstract:
    Objective To investigate the impact of body mass index (BMI) on the outcome of intrauterine insemination (IUI) for infertility patients.
    Methods A total of 1 393 infertility patients undergoing their first cycle of IUI were selected as study subjects, and were divided into normal BMI group (n=824), overweight group (n=394) and obese group (n=175) based on BMI. Age, duration of infertility, type of infertility, sex hormones, fasting blood glucose, fasting insulin, thyroid function, timing of insemination, number of progressively motile spermatozoa, biochemical pregnancy rate, clinical pregnancy rate and miscarriage rate were compared among the three groups. Multiple linear regression analysis was used to analyze the influencing factors of BMI; the effects of age, BMI, fasting blood glucose and fasting insulin on IUI outcome were analyzed by binary Logistic regression. Receiver operating characteristic (ROC) curve was drawn to analyze the predictive value of BMI for biochemical pregnancy and clinical pregnancy, and the cut-off value was calculated.
    Results There were no significant differences in age, time of insemination, number of progressively motile spermatozoa, clinical pregnancy rate and miscarriage rate among the three groups (P>0.05). The duration of infertility, fasting blood glucose and fasting insulin levels in the obese and overweight groups were significantly longer or higher than those in the normal BMI group (P < 0.05). The follicle-stimulating hormone (FSH) level in the obese group was significantly lower, while the free thyroxine (FT4) level in the obese group was significantly higher than that in the overweight group and normal BMI group (P < 0.05). The biochemical pregnancy rate in the obese group was significantly higher than that in the normal BMI group (P < 0.05). Multiple linear regression analysis showed that BMI was negatively correlated with FSH and estradiol (E2) (P < 0.01) and positively correlated with fasting blood glucose and fasting insulin (P < 0.01). Multivariate binary logistic regression analysis showed that age and BMI were influencing factors for clinical pregnancy (P < 0.05), while age, BMI, and fasting insulin were influencing factors for biochemical pregnancy (P < 0.05). The ROC curve showed that the area under the curve (AUC) for BMI predicting biochemical pregnancy and clinical pregnancy was 0.608 and 0.610, respectively, with a cut-off value of 23.05 kg/m2 for both.
    Conclusion BMI affects the endocrine and glycolipid metabolism of infertility patients. BMI can be used as an independent factor to predict biochemical pregnancy and clinical pregnancy in IUI.

     

/

返回文章
返回